A股異動 | 貴州百靈漲超8% 三款藥品入選新冠感染居家中醫藥干預指引
格隆匯12月12日丨貴州百靈(002424.SZ)再度拉昇漲超8%,11月底以來累計漲幅高達45%,現報10.7元,總市值超150億元。12月10日,國家中醫藥管理局正式發佈《新冠病毒感染者居家中醫藥干預指引》,對民眾居家服用藥物作出指導。其中,貴州百靈獨家苗藥“咳速停糖漿”、獨家品規“小兒柴桂退熱顆粒”以及小柴胡顆粒等產品順利入選,分別被列為成人及兒童治療推薦用藥,為民眾居家用藥提供新的選擇。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.